Butyric Acid

Butyric Acid

SCHEMBL40619

CCCC(=O)O.CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL7292351 1.00 FFAR3 (0.93)
Butyric Acid SCHEMBL1976481 0.97
Butyric Acid SCHEMBL4781139 0.97
Butyric Acid SCHEMBL8458708 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL8457839 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL1332215 0.96
Butyric Acid SCHEMBL991717 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL20678495 0.96
Butyric Acid SCHEMBL4446516 0.96 FFAR3 (1.00)
Butyric Acid SCHEMBL320515 0.96 FFAR3 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3896050-B1 METHOD FOR PREPARING CANNABIDIOL BY MEANS OF HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY SEPARATION AND PURIFICATION TECHSON INDUSTRY COMPANY LTD (HK) 2024-06-19 EP claimed
EP-2956439-B1 PROCESS FOR PREPARING ATAZANAVIR SULPHATE CIPLA LTD (IN) 2019-01-09 EP claimed
US-7799928-B2 Process for the preparation of irbesartan hydrochloride CIPLA LIMITED (IN) 2010-09-21 US claimed
CN-101775418-A Method for extracting, separating and purifying formononetin and calycosin from Astragalus mongholicus waste residue UNIV NORTHEAST FORESTRY 2010-07-14 CN claimed
US-20090137648-A1 PROCESS FOR THE PREPARATION OF IRBESARTAN HYDROCHLORIDE CIPLA LIMITED (IN) 2009-05-28 US claimed
WO-2005092908-A1 BASE ADDITION SALTS OF MONOSACCHARIDES DERIVATIVES AS INHIBITORS OF AIRWAY HYPER REACTIVITY AND AIRWAY INFLAMMATION RANBAXY LABORATORIES LIMITED (IN) 2005-10-06 WO claimed
EP-0182152-B1 Antitumor antibiotics (LL-E33288 Complex) AMERICAN CYANAMID CO (US) 1999-05-26 EP claimed
EP-0464009-B1 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same SIGMA TAU IND FARMACEUTI (IT) 1998-05-13 EP claimed
US-12421204-B2 Process for preparing chroman compounds LUPIN LIMITED (IN) 2025-09-23 US disclosed
EP-4090654-B1 METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS LUPIN LTD (IN) 2025-07-09 EP disclosed
US-12344592-B2 Methods, processes and intermediates for preparing chroman compounds LUPIN LIMITED (IN) 2025-07-01 US disclosed
US-20250122228-A1 METAL-ORGANIC COORDINATION COMPOUND COMPRISING CERIUM(III) BEEOLED GMBH (DE) 2025-04-17 US disclosed
US-12257280-B2 Composition for preventing or treating muscular diseases, containing, as active ingredient, Glycyrrhiza uralensis extract or compound isolated therefrom NEO CREMAR CO., LTD. (KR) 2025-03-25 US disclosed
US-20250066358-A1 Inhibitors of Menin-MLL Interaction BALA THERAPEUTICS, INC. 2025-02-27 US disclosed
US-4032641-A HYPOLIPIDEMIC AGENTS TANABE SEIYAKU CO., LTD. (JA) 1977-06-28 US disclosed
US-4029672-A Aminoalkylpyrrolobenzoxazalkanes AMERICAN HOECHST CORPORATION (US) 1977-06-14 US disclosed
US-4025619-A MYCOPLASMA SP. RP III WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1977-05-24 US disclosed
US-4009175-A 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines THE UPJOHN COMPANY (US) 1977-02-22 US disclosed
US-4006232-A Therapeutic method of treating cardiac arrhythmias utilizing 3-substituted diphenylhydantoins MILES LABORATORIES, INC. (US) 1977-02-01 US disclosed
US-3988314-A VIRICIDES; 1-METHYL-PSEUDOURIDINE; FERMENTATION OF STREPTOMYCES THE UPJOHN COMPANY (US) 1976-10-26 US disclosed